Services Built for Translational Reality

Integrated R&D, regulatory & quality, clinical, and market strategy designed to reduce risk, improve decision-making, and accelerate patient impact.

R&D / Preclinical

We guide early and mid-stage development with a translational lens — ensuring technical decisions align with regulatory expectations, clinical feasibility, and downstream commercialization.

  • • Assist with creation of user needs user & targets product profile (TPP)
  • • Design input & development oversight
  • • Cost- and time-efficient testing strategies
  • • Design of full biological testing portfolio
  • • Protocols and execution - from feasibility, pilot, to GLP
  • • Experts in custom ISO 10993
Development strategy placeholder

Regulatory & Quality

Regulatory and quality considerations are embedded early — not layered on after development decisions have already been made.

  • • Global regulatory pathway strategy
  • • FDA & international agency interaction & submission support
  • • Design controls & quality system integration
  • • Risk management (ISO 14971)
  • • Guidance on phase-appropraite QMS
  • • 21 CFR, ISO, MDR/IVDR, and MDSAP expertise
Regulatory and quality placeholder

Clinical Research & Operations

Sigma designs clinical strategies that balance scientific rigor with operational feasibility and regulatory acceptance.

  • • Clinical strategy & endpoint selection
  • • Protocol and clinical document development
  • • CRO selection & management
  • • Investigator & site engagement
  • • Operational strategy, including filling fractional roles (e.g., PM or PD)
  • • Investigator meetings & Troubleshooting and rescues
Clinical placeholder

Market Success

We support post-market activities that meet regulatory requirements while generating meaningful, defensible real-world data.

  • • Post-market surveillance planning
  • • Clinical education support
  • • Sales & marketing enablement (compliant)
  • • Field assurance & complaint handling
  • • Ongoing regulatory compliance support
Post-market placeholder

KOL Engagement

We are connected with over a hundred physician key opinion leaders, industry subject matter experts, and other scientific minds that can be tapped for:

  • • End user/voice of customer
  • • Product preference and publications
  • • Investigators
  • • Board members: company, scientific advisory, steering committee
  • • Surgical wetlab and training
  • • Comprehensive event planning
KOL engagement placeholder

Due Diligence

  • • Commercial/market strategy due diligence
  • • Technical due diligence
  • • Regulatory compliance and development strategy due diligence
  • • M&A advisement
  • • Can support Manufacturer, VC, PE, family offices, & investment banking
Due diligence placeholder
Replace with due diligence, investment review, or advisory visual.

Let’s Build With Sigma

Whether you are early-stage or post-market, Sigma Bio Consulting helps align science, medicine, regulation, and business, and execution.